Mendel Goldfinger
@mendelgoldfing2
ID: 1382727970385768450
15-04-2021 16:10:28
5 Tweet
47 Takipçi
18 Takip Edilen
🔥 Our clinical trial of metronomic low-dose decitabine-ven in frontline MDS/ AML shows low tox, high efficacy & high response rate in TP53 mutant pts!! pubmed.ncbi.nlm.nih.gov/39316768/ Amit Verma Aditi Shastri, MD Ioannis Mantzaris Marina Konopleva Yogen Saunthararajah Montefiore Health System Albert Einstein College of Medicine - Official #leusm